REATA PHARMACEUTICALS INC Retained Earnings
REATA PHARMACEUTICALS INC had Retained Earnings of -$1.49 billion as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-08-08
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$1.49B.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$1.68B.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$1.57B.
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$1.48B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-06-30 | -$1.49B 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$1.68B 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$1.57B 10-Q · filed 2023-08-08 |
| 2022-09-30 | -$1.48B 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$1.40B 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$1.33B 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$1.26B 10-K · filed 2023-02-24 |
| 2021-09-30 | -$1.17B 10-Q · filed 2021-11-08 |
| 2021-06-30 | -$1.10B 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$1.03B 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$958.25M 10-K · filed 2022-02-28 |
| 2020-09-30 | -$892.47M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$827.01M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$759.43M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$710.49M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$523.55M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$483.86M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$449.48M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$420.32M 10-K · filed 2020-02-19 |
| 2018-09-30 | -$394.76M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$363.91M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$335.69M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$337.14M 10-K · filed 2019-02-28 |
| 2017-09-30 | -$320.46M 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$308.15M 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$296.56M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$289.35M 10-K · filed 2018-03-02 |
| 2016-09-30 | -$285.22M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$284.32M 10-Q · filed 2016-08-11 |
| 2015-12-31 | -$283.13M 10-K · filed 2017-03-03 |